Sharp cuts in cancer drug prices expose excessive pricing, health experts say
What happened
According to The Hindu, health experts say sharp cuts in the price of cancer drugs show that prices were excessive. The report's details, such as the drugs and amounts involved, were not available in the information provided.
When it started
The topic was first reported on 28 October 2026, according to the trending data. The exact date of the underlying article was not provided.
How it spread
The story is based on a single report from The Hindu, which quotes health experts. Other outlets' coverage and official pricing data were not included in the information provided.
Why it matters
The story matters because cancer drug costs affect patients and health systems in India. The reported price cuts have led experts to question how drugs were priced before the cuts.